Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Bulbo-Spinal Atrophy, X-Linked × AZD5305 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 4 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Bulbo-Spinal Atrophy, X-Linked 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

enzalutamide 1 darolutamide 1 abiraterone 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07336446 2026-01-13

ANDROMEDA

AstraZeneca

Phase 1/2 Not yet recruiting

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡